BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1166 related articles for article (PubMed ID: 16728461)

  • 1. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.
    van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP
    Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.
    Kane D; Gogarty M; O'leary J; Silva I; Bermingham N; Bresnihan B; Fitzgerald O
    Arthritis Rheum; 2004 Oct; 50(10):3286-95. PubMed ID: 15476228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
    Danning CL; Illei GG; Hitchon C; Greer MR; Boumpas DT; McInnes IB
    Arthritis Rheum; 2000 Jun; 43(6):1244-56. PubMed ID: 10857783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment.
    Kraan MC; Reece RJ; Smeets TJ; Veale DJ; Emery P; Tak PP
    Arthritis Rheum; 2002 Aug; 46(8):2034-8. PubMed ID: 12209505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
    Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
    Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
    Noordenbos T; Yeremenko N; Gofita I; van de Sande M; Tak PP; Caňete JD; Baeten D
    Arthritis Rheum; 2012 Jan; 64(1):99-109. PubMed ID: 21968742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.
    Kane D; Jensen LE; Grehan S; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2004 Jul; 31(7):1274-80. PubMed ID: 15229943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
    Roelofs MF; Wenink MH; Brentano F; Abdollahi-Roodsaz S; Oppers-Walgreen B; Barrera P; van Riel PL; Joosten LA; Kyburz D; van den Berg WB; Radstake TR
    Ann Rheum Dis; 2009 Sep; 68(9):1486-93. PubMed ID: 18765427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
    Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
    Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of cytokine production in psoriatic synovium.
    Ritchlin C; Haas-Smith SA; Hicks D; Cappuccio J; Osterland CK; Looney RJ
    J Rheumatol; 1998 Aug; 25(8):1544-52. PubMed ID: 9712099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.
    Gerlag DM; Haringman JJ; Smeets TJ; Zwinderman AH; Kraan MC; Laud PJ; Morgan S; Nash AF; Tak PP
    Arthritis Rheum; 2004 Dec; 50(12):3783-91. PubMed ID: 15593225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative histopathological analysis between tenosynovitis and joint synovitis in rheumatoid arthritis.
    Kaibara N; Yamada H; Shuto T; Nakashima Y; Okazaki K; Miyahara H; Esaki Y; Hirata G; Iwamoto Y
    Histopathology; 2008 Jun; 52(7):856-64. PubMed ID: 18462359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis.
    Harty LC; Biniecka M; O'Sullivan J; Fox E; Mulhall K; Veale DJ; Fearon U
    Ann Rheum Dis; 2012 Apr; 71(4):582-8. PubMed ID: 22121133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.